Cemiplimab Now Approved for Basal Cell Carcinoma ...Middle East

News by : (Medscape) -
The FDA has approved the immunotherapy for patients with locally advanced or metastatic basal cell carcinoma previously treated with a hedgehog pathway inhibitor or for whom an HHI is inappropriate. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Cemiplimab Now Approved for Basal Cell Carcinoma )

Also on site :

Most Viewed News
جديد الاخبار